Jefferies John Officer Transaction

2026-09-01SEC Filing 4 (0001493152-26-040999)

John Jefferies, Chief Medical Officer of DAXOR CORP, acquired 2,451 shares of Daxor Common Stock on August 28, 2026. The shares were granted and vest on August 28, 2026. The transaction code was 'A' for acquisition, with a price per share of 0.0. Following the transaction, Jefferies owns 26,008 shares directly. This filing is a Form 4, indicating a change in beneficial ownership.